Plain-English translation of NCT07165210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to better understand how esophageal cancer spreads to lymph nodes — small immune glands in your chest — during surgery. By following patients like you who are having esophageal cancer surgery, they can figure out which lymph nodes are most important to remove and which patients are at higher risk of cancer spreading to specific areas.
Right now, doctors aren't always sure which lymph nodes need to be removed during esophageal cancer surgery. Removing certain lymph nodes can sometimes cause serious side effects like difficulty swallowing or breathing problems. This study will help doctors understand which patients really need those nodes removed and which ones may be safely spared from surgery.
You likely qualify if…
You likely don't qualify if…
You would participate by having your esophageal cancer surgery as planned — the study does not add any new procedures or medications. Researchers will collect information from your medical records about where your cancer is located, which lymph nodes are involved, and the extent of your surgery. After surgery, they will follow your health outcomes over time to see which patients develop cancer recurrence and whether specific lymph node involvement affects your long-term survival.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China
Sponsor
Fudan University
Enrollment target
~1,852 participants
Started
July 2025
Primary completion
July 2027
Age range
20 Years – 85 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bin Li, MD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.